The synthetic cannabinoid AB-FUBINACA caused physical dependence in mice despite its short duration of action
AB-FUBINACA, a potent third-generation synthetic cannabinoid, produced classic cannabinoid effects that wore off quickly but still induced physical dependence after repeated dosing in mice.
Quick Facts
What This Study Found
AB-FUBINACA at 2+ mg/kg produced catalepsy, antinociception, hypothermia, and reduced locomotion, all blocked by CB1 antagonist rimonabant. Despite being undetectable in brain tissue by 4 hours, twice-daily dosing for 5 days produced somatic withdrawal signs (head twitches, paw tremors) when precipitated by rimonabant.
Key Numbers
AB-FUBINACA effects at 2+ mg/kg. Undetectable in brain by 4 hours post-injection. 5 days of twice-daily dosing produced dependence. No tolerance developed to AB-FUBINACA or cross-tolerance to THC (50 mg/kg).
How They Did This
Male and female C57BL/6J mice received AB-FUBINACA (0-3 mg/kg) and were tested in the tetrad battery. For dependence assessment, mice were dosed every 12 hours for 5 days, then withdrawal was precipitated with rimonabant on day 6. Brain levels were quantified by UHPLC-MS/MS.
Why This Research Matters
Synthetic cannabinoids are often assumed to be similar to plant cannabis, but their rapid action and potency may create a distinct dependence risk. This study shows that even short-acting synthetic cannabinoids can induce physical dependence.
The Bigger Picture
Third-generation synthetic cannabinoids like AB-FUBINACA are increasingly found in unregulated drug markets. Understanding their rapid onset, short duration, and dependence potential is critical for emergency medicine and addiction treatment.
What This Study Doesn't Tell Us
Animal study using intraperitoneal and subcutaneous injection, which differs from how humans typically use synthetic cannabinoids (inhalation). Only one dosing regimen tested. Withdrawal was precipitated rather than spontaneous.
Questions This Raises
- ?Do users of synthetic cannabinoids experience a distinct withdrawal pattern compared to plant cannabis users?
- ?Could the rapid clearance of AB-FUBINACA contribute to compulsive redosing?
- ?How do dependence profiles compare across different generations of synthetic cannabinoids?
Trust & Context
- Key Stat:
- Physical dependence after just 5 days of twice-daily dosing
- Evidence Grade:
- Well-controlled preclinical study with pharmacokinetic data, but animal model may not fully predict human dependence patterns.
- Study Age:
- 2020 animal study. Relevant to ongoing public health concerns about synthetic cannabinoids in unregulated drug markets.
- Original Title:
- The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.
- Published In:
- Drug and alcohol dependence, 214, 108179 (2020)
- Authors:
- Trexler, Kristen R(2), Vanegas, S Olivia(3), Poklis, Justin L(5), Kinsey, Steven G
- Database ID:
- RTHC-02885
Evidence Hierarchy
Tests effects in animals (usually mice or rats), not humans.
What do these levels mean? →Frequently Asked Questions
What is AB-FUBINACA?
AB-FUBINACA is a third-generation synthetic cannabinoid, a lab-made compound that activates the same CB1 receptors as THC but with much greater potency and shorter duration of action.
How is AB-FUBINACA different from THC?
AB-FUBINACA was undetectable in the brain 4 hours after injection, while THC effects lasted much longer. Despite this short duration, AB-FUBINACA still caused physical dependence. Mice also did not develop cross-tolerance between the two compounds.
Read More on RethinkTHC
- 30-days-without-weed
- 6-months-sober-weed-what-to-expect
- 90-days-no-weed
- THC-purity-potency-label-meaning
- benefits-of-quitting-weed
- boredom-after-quitting-weed
- boredom-after-quitting-weed-nothing-fun
- creativity-without-weed-quitting-artist-musician
- dab-concentrate-addiction-withdrawal
- delta-8-addiction-withdrawal
- edible-addiction-withdrawal-different
- edibles-psychosis-emergency-room
- healthiest-way-to-consume-cannabis
- hobbies-after-quitting-weed
- how-cannabis-products-made-concentrates-edibles
- identity-after-quitting-weed
- laced-weed-fentanyl-contaminated-vape
- leaving-stoner-culture-identity
- legal-weed-vs-street-weed-quality-safety
- money-saved-quitting-weed-calculator
- one-year-sober-weed
- quitting-dabs-withdrawal
- quitting-edibles-withdrawal
- quitting-weed-creativity
- quitting-weed-face-changes-skin
- quitting-weed-weight-loss-gain
- sativa-vs-indica-difference-myth
- weed-potency-withdrawal
Cite This Study
https://rethinkthc.com/research/RTHC-02885APA
Trexler, Kristen R; Vanegas, S Olivia; Poklis, Justin L; Kinsey, Steven G. (2020). The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.. Drug and alcohol dependence, 214, 108179. https://doi.org/10.1016/j.drugalcdep.2020.108179
MLA
Trexler, Kristen R, et al. "The short-acting synthetic cannabinoid AB-FUBINACA induces physical dependence in mice.." Drug and alcohol dependence, 2020. https://doi.org/10.1016/j.drugalcdep.2020.108179
RethinkTHC
RethinkTHC Research Database. "The short-acting synthetic cannabinoid AB-FUBINACA induces p..." RTHC-02885. Retrieved from https://rethinkthc.com/research/trexler-2020-the-shortacting-synthetic-cannabinoid
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.